Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 1999, p. 2663-2670, Vol. 43, No. 11
Anti-Infectives Research
Departments,1 Immunology
Department,3 Analytical
Department,4 and Biotechnology
Department,5 Janssen Research Foundation,
Beerse, Belgium; Institut de Microbiologie, Centre
Hospitalier Universitaire Vaudois, Lausanne,
Switzerland6; and Department of
Molecular Cell Biology & Genetics, University Maastricht,
Maastricht, The Netherlands2
Received 20 May 1999/Returned for modification 11 August
1999/Accepted 1 September 1999
The effects of itraconazole on ergosterol biosynthesis were
investigated in a series of 16 matched clinical Candida
albicans isolates which had been previously analyzed for
mechanisms of resistance to azoles (D. Sanglard, K. Kuchler, F. Ischer,
J. L. Pagani, M. Monod, and J. Bille, Antimicrob. Agents
Chemother., 39:2378-2386, 1995). Under control conditions, all
isolates contained ergosterol as the predominant sterol, except two
strains (C48 and C56). In isolates C48 and C56, both less susceptible
to azoles than their parent, C43, substantial concentrations (20 to
30%) of 14
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Accumulation of 3-Ketosteroids Induced by
Itraconazole in Azole-Resistant Clinical Candida
albicans Isolates
and
-methyl-ergosta-8,24(28)-diene-3
,6
-diol (3,6-diol)
were found. Itraconazole treatment of C43 resulted in a dose-dependent inhibition of ergosterol biosynthesis (50% inhibitory concentration, 2 nM) and accumulation of 3,6-diol (up to 60% of the total sterols) together with eburicol, lanosterol, obtusifoliol,
14
-methyl-ergosta-5,7,22,24(28)-tetraene-3
ol, and
14
-methyl-fecosterol. In strains C48 and C56, no further increase of
3,6-diol was observed after exposure to itraconazole. Ergosterol
synthesis was less sensitive to itraconazole inhibition, as was
expected for these azole-resistant isolates which overexpress ATP-binding cassette transporter genes CDR1 and
CDR2. In addition to 3,6-diol, substantial amounts of
obtusifolione were found after exposure to itraconazole. This toxic
3-ketosteroid was demonstrated previously to accumulate after
itraconazole treatment in Cryptococcus neoformans and
Histoplasma capsulatum but has not been reported in
Candida isolates. Accumulation of obtusifolione correlated with nearly complete growth inhibition in these azole-resistant strains
compared to that found in the susceptible parent strain, although the
onset of growth inhibition only occurred at higher concentrations of
itraconazole. ERG25 and ERG26 are the only
genes assigned to the 4-demethylation process, of which the
3-ketoreductase is part. To verify whether mutations in these
ERG25 genes contributed to obtusifolione accumulation,
their nucleotide sequences were determined in all three related
isolates. No mutations in ERG25 alleles of isolates C48 and
C56 were found, suggesting that this gene is not involved in
obtusifolione accumulation. The molecular basis for the accumulation of
this sterol in these two strains remains to be established.
*
Corresponding author. Mailing address: Janssen Research
Foundation Infectious Diseases Research Departments, Turnhoutseweg 30, B2340 Beerse, Belgium. Phone: 32 14 60 31 97. Fax: 32 14 60 54 03. E-mail: pmaricha{at}janbe.jnj.com.
Present address: Department of Molecular Cell Biology, University
of Aberdeen Institute of Medical Sciences, Foresterhill, Aberdeen AB25
2ZD, Scotland.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»